Biomarkers: Validation & Verification


Biomarker discovery requires high confidence identification of biomarker candidates with simultaneous quantitation information to indicate which proteins are changing to a statistically relevant degree in response to disease. Because of normal clinical or biological variability, candidate biomarkers identified in the discovery stage need to be validated across a large number of samples. The challenge is to develop a fast, targeted analysis method capable of analyzing as many identified candidates as possible in minimally hundreds and potentially even thousands of samples.


    Related Conference of Biomarkers: Validation & Verification

    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, France
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    May 20-21, 2026

    30th World Congress on Biotechnology

    Rome, Italy
    June 29-30, 2026

    41st International Conference on Next-Gen Biotechnology and Applications

    Aix-en-Provence, France
    July 23-24, 2026

    27th Global Summit on Analytical and Bioanalytical Techniques

    Paris, France
    August 13-14, 2026

    21st World Congress on Biomarkers, Cancer Therapy & Clinical Research

    San Diego, USA
    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany
    September 21-22, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    November 16-17, 2026

    8th International Conference on Biochemistry

    Tokyo, Japan

    Biomarkers: Validation & Verification Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in